Total Visits
| Views | |
|---|---|
| Molecular ... | 48 |
Total Visits Per Month
| June 2023 | July 2023 | August 2023 | September 2023 | October 2023 | November 2023 | December 2023 | |
|---|---|---|---|---|---|---|---|
| Molecular ... | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
File Visits
| Views | |
|---|---|
| molecular_clinical_determinants_response_resistance_rucaparib_recurrent_ovarian_cancer_treatment_ariel2_parts_1_2_2021.pdf | 145 |
| molecular_clinical_determinants_response_resistance_rucaparib_recurrent_ovarian_cancer_treatment_ariel2_parts_1_2_2021_material_suplementari1.pdf | 42 |
| molecular_clinical_determinants_response_resistance_rucaparib_recurrent_ovarian_cancer_treatment_ariel2_parts_1_2_2021_material_suplementari2.pdf | 12 |
Top country views
| Views | |
|---|---|
| United States | 34 |
| Spain | 6 |
| Germany | 2 |
| France | 2 |
| Australia | 1 |
| Belgium | 1 |
| Finland | 1 |
| Sweden | 1 |
Top cities views
| Views | |
|---|---|
| Chandler | 11 |
| Ashburn | 3 |
| Barcelona | 3 |
| Phoenix | 2 |
| Brussels | 1 |
| Cheyenne | 1 |
| Chicago | 1 |
| Des Moines | 1 |
| Helsinki | 1 |
| Madrid | 1 |